Chemical Structure : Tivantinib
CAS No.: 905854-02-6
货号: PC-45842Not For Human Use, Lab Use Only.
Tivantinib (ARQ-197) is a potent, selective, non-ATP-competitive inhibitor of c-Met with Ki of 355 nM.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | ¥780 | In stock | |
25 mg | ¥1280 | In stock | |
50 mg | ¥2180 | In stock | |
100 mg | ¥3580 | In stock | |
250 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Tivantinib (ARQ-197) is a potent, selective, non-ATP-competitive inhibitor of c-Met with Ki of 355 nM.
Tivantinib (ARQ-197) has no inhibition for EGFR, InsR, PDGFRα, FGFR1 and FGFR4 etc., only modest inhibition (35%) for Ron at 30 uM.
Tivantinib (ARQ-197) inhibits constitutive c-Met phosphorylation in HT29 and MKN-45 cells, and HGF-induced c-Met phosphorylation in MDA-MB-231 and NCI-H441 cells with IC50 of 100-300 nM.
Tivantinib (ARQ-197) shows antiproliferative activity against multiple cancer cell lines (IC50=0.03-30 uM).
Tivantinib (ARQ-197) exerts tumor growth inhibition in multiple mouse xenograft; orally active.
分子量 | 369.4159 | |
分子式 | C23H19N3O2 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
2,5-Pyrrolidinedione, 3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-, (3R,4R)- |
1. Munshi N, et al. Mol Cancer Ther. 2010 Jun;9(6):1544-53.
2. Eathiraj S, et al. J Biol Chem. 2011 Jun 10;286(23):20666-76.
3. Previdi S, et al. Mol Cancer Ther. 2012 Jan;11(1):214-23.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright